Research Output per year
Fingerprint Dive into the research topics where Anna Zaniboni is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 33 Similar Profiles
Seizures
Medicine & Life Sciences
Colorectal Neoplasms
Medicine & Life Sciences
Electroencephalography
Medicine & Life Sciences
Epilepsy
Medicine & Life Sciences
Sleep
Medicine & Life Sciences
Myoclonus
Medicine & Life Sciences
Status Epilepticus
Medicine & Life Sciences
Disease-Free Survival
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output 1996 2020
Khorana score and thromboembolic risk in stage II–III colorectal cancer patients: a post hoc analysis from the adjuvant TOSCA trial
Barni, S., Rosati, G., Lonardi, S., Pella, N., Banzi, M., Zampino, M. G., Dotti, K. F., Rimassa, L., Marchetti, P., Maiello, E., Artioli, F., Ferrari, D., Labianca, R., Bidoli, P., Zaniboni, A., Sobrero, A., Iaffaioli, V., De Placido, S., Frassineti, G. L., Ciarlo, A. & 11 others, , Jan 1 2020, In : Therapeutic Advances in Medical Oncology. 12Research output: Contribution to journal › Article
Open Access
Colorectal Neoplasms
Adjuvant Chemotherapy
Confidence Intervals
Logistic Models
Survival
Neutropenia and survival outcomes in metastatic colorectal cancer patients treated with trifluridine/tipiracil in the RECOURSE and J003 trials
Yoshino, T., Cleary, J. M., Van Cutsem, E., Mayer, R. J., Ohtsu, A., Shinozaki, E., Falcone, A., Yamazaki, K., Nishina, T., Garcia-Carbonero, R., Komatsu, Y., Baba, H., Argilés, G., Tsuji, A., Sobrero, A., Yamaguchi, K., Peeters, M., Muro, K., Zaniboni, A., Sugimoto, N. & 12 others, , Jan 2020, In : Annals of Oncology. 31, 1, p. 88-95 8 p.Research output: Contribution to journal › Article
Open Access
Trifluridine
Neutropenia
Colorectal Neoplasms
Survival
Drug Therapy
Assessment of Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line chemotherapy in patients with advanced HER-2 negative gastric or gastroesophageal junction cancers: The ARMANI phase III trial
Di Bartolomeo, M., Niger, M., Morano, F., Corallo, S., Antista, M., Tamberi, S., Lonardi, S., Di Donato, S., Berardi, R., Scartozzi, M., Cardellino, G. G., Di Costanzo, F., Rimassa, L., Luporini, A. G., Longarini, R., Zaniboni, A., Bertolini, A., Tomasello, G., Pinotti, G., Scagliotti, G. & 19 others, , Mar 29 2019, In : BMC Cancer. 19, 1, 283.Research output: Contribution to journal › Article
Esophagogastric Junction
Paclitaxel
Stomach
Maintenance
Drug Therapy
Assessment of Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line chemotherapy in patients with advanced HER-2 negative gastric or gastroesophageal junction cancers: The ARMANI phase III trial
Di Bartolomeo, M., Niger, M., Morano, F., Corallo, S., Antista, M., Tamberi, S., Lonardi, S., Di Donato, S., Berardi, R., Scartozzi, M., Cardellino, G. G., Di Costanzo, F., Rimassa, L., Luporini, A. G., Longarini, R., Zaniboni, A., Bertolini, A., Tomasello, G., Pinotti, G., Scagliotti, G. & 19 others, , 2019, In : BMC Cancer. 19, 1Research output: Contribution to journal › Article
Corrigendum to “Gastric cancer: Translating novels concepts into clinical practice” (Cancer Treatment Reviews (2019) 79, (S0305737219300969), (10.1016/j.ctrv.2019.101889))
Salati, M., Orsi, G., Smyth, E., Aprile, G., Beretta, G., De Vita, F., Di Bartolomeo, M., Fanotto, V., Lonardi, S., Morano, F., Pietrantonio, F., Pinto, C., Rimassa, L., Vasile, E., Vivaldi, C., Zaniboni, A., Ziranu, P. & Cascinu, S., Dec 2019, In : Cancer Treatment Reviews. 81, 101932.Research output: Contribution to journal › Comment/debate
Open Access
Authorship
Translating
Stomach Neoplasms
Italy
Neoplasms